Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Travere Therapeutics Inc shares valued at $631 were sold by Cline Christopher R. on Apr 11 ’25. At $13.14 per share, Cline Christopher R. sold 48 shares. The insider’s holdings dropped to 89,990 shares worth approximately $1.59 million following the completion of this transaction.
Also, Christopher Cline purchased 48 shares, netting a total of over 631 in proceeds.
Before that, ROTE WILLIAM E. had sold 5,200 shares from its account. In a trade valued at $122,356, the SENIOR VICE PRESIDENT, R&D traded Travere Therapeutics Inc shares for $23.53 each. Upon closing the transaction, the insider’s holdings decreased to 5,200 shares, worth approximately $1.74 million.
As published in their initiating research note from Cantor Fitzgerald on January 10, 2025, Travere Therapeutics Inc [TVTX] has been an Overweight. Analysts at Wells Fargo upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in late October. As of October 16, 2024, Scotiabank has initiated its “Sector outperform” rating for TVTX. Earlier on September 09, 2024, Guggenheim upgraded its rating. Their new recommendation was “a Buy” for TVTX stock which previously was a “a Neutral”.
Analyzing TVTX Stock Performance
During the last five days, there has been a surge of approximately 21.00%. Over the course of the year, Travere Therapeutics Inc shares have jumped approximately 1.21%. Shares of the company reached a 52-week high of $25.29 on 02/11/25 and a 52-week low of $12.91 on 04/09/25. A 50-day SMA is recorded $18.87, while a 200-day SMA reached $16.19.
Support And Resistance Levels for Travere Therapeutics Inc (TVTX)
According to the 24-hour chart, there is a support level at 17.03, which, if violated, would cause prices to drop to 16.43. In the upper region, resistance lies at 17.96. The next price resistance is at 18.28. RSI (Relative Strength Index) is 54.86 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.65, which suggests the price will increase in the coming days. Percent R is at 1.15%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
